Cerity Partners
IMNM icon

Cerity Partners’s Immunome IMNM Stock Holding History

Cerity Partners’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Sell
77,561
-6,020
-7% -$129K ﹤0.01% 1699
2026
Q1 		$1.83M Buy
83,581
+40,789
+95% +$908K ﹤0.01% 1541
2025
Q4 		$919K Sell
42,792
-3,086
-7% -$54.2K ﹤0.01% 1754
2025
Q3 		$537K Sell
45,878
-654
-1% -$6.51K ﹤0.01% 1927
2025
Q2 		$433K Sell
46,532
-5,527
-11% -$45.3K ﹤0.01% 1946
2025
Q1 		$350K Sell
52,059
-619
-1% -$5.94K ﹤0.01% 1943
2024
Q4 		$663K Sell
52,678
-425
-0.8% -$5.14K ﹤0.01% 1610
2024
Q3 		$776K Buy
53,103
+5,043
+10% +$71.7K ﹤0.01% 1532
2024
Q2 		$582K Sell
48,060
-31,163
-39% -$487K ﹤0.01% 1474
2024
Q1 		$1.96M Buy
79,223
+17,877
+29% +$363K 0.01% 981
2023
Q4 		$656K Buy
+61,346
New +$510K ﹤0.01% 1156
2023
Q3 		– Sell
-67,126
Closed -$531K – 1546
2023
Q2 		$531K Buy
67,126
+13,779
+26% +$75.3K ﹤0.01% 1152
2023
Q1 		$266K Hold
53,347
– – ﹤0.01% 1590
2022
Q4 		$118K Sell
53,347
-3,615
-6% -$14.6K ﹤0.01% 1399
2022
Q3 		$253K Hold
56,962
– – ﹤0.01% 965
2022
Q2 		$183K Sell
56,962
-36,584
-39% -$133K ﹤0.01% 1088
2022
Q1 		$531K Sell
93,546
-1,180
-1% -$8.82K 0.01% 579
2021
Q4 		$1.23M Sell
94,726
-7,278
-7% -$130K 0.02% 403
2021
Q3 		$2.48M Sell
102,004
-2,485
-2% -$43.3K 0.05% 237
2021
Q2 		$1.81M Sell
104,489
-5,838
-5% -$129K 0.04% 279
2021
Q1 		$3.74M Sell
110,327
-12,219
-10% -$304K 0.09% 174
2020
Q4 		$1.19M Buy
+122,546
New +$1.43M 0.04% 284

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Cerity Partners's IMNM Position: Q2 2026 in Review

Cerity Partners reduced its Immunome (IMNM) stake by 7.2% in Q2 2026, selling an estimated $129K and leaving 77,561 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #1699.

Cerity Partners first reported a position in IMNM in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.74M in Q1 2021. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Cerity Partners held 77,561 shares of Immunome worth $1.64M as of Q2 2026.
  • Cerity Partners sold 6,020 Immunome shares in Q2 2026, an estimated $129K.
  • Immunome made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1699 holding.
  • Cerity Partners first reported a position in Immunome in Q4 2020 and has held it in 22 quarters since.
  • Cerity Partners's Immunome position peaked at $3.74M in Q1 2021.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.